tiprankstipranks
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
Australian Market
Holding AU:AFP?
Track your performance easily

AFT Pharmaceuticals Ltd. (AFP) Share Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

AFP Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
AFT
Pharmaceuticals Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AFP Stock 12 Month Forecast

There Are No Analyst Ratings for AU:AFP In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

AFP Financial Forecast

AFP Earnings Forecast

The previous quarter’s earnings for AFP were -AU$0.02.
The previous quarter’s earnings for AFP were -AU$0.02.

AFP Sales Forecast

Next quarter’s sales forecast for AFP is AU$114.85M with a range of AU$114.85M to AU$114.85M. The previous quarter’s sales results were AU$79.35M. AFP beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 52.25% of the time in the same period. In the last calendar year AFP has Underperformed its overall industry.
Next quarter’s sales forecast for AFP is AU$114.85M with a range of AU$114.85M to AU$114.85M. The previous quarter’s sales results were AU$79.35M. AFP beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 52.25% of the time in the same period. In the last calendar year AFP has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jarden
Hold
Upgraded
05/24/24

AFP Analyst Recommendation Trends

Rating
Nov 22
Jan 23
Nov 23
Feb 24
May 24
Strong Buy
1
0
0
0
0
Buy
0
0
0
0
0
Hold
2
3
3
2
2
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, AFP has received 0 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. AFP average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AFP Stock Forecast FAQ

What is AU:AFP’s average 12-month price target, according to analysts?
Currently, no data Available
What is AU:AFP’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AU:AFP, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is AFT Pharmaceuticals Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is AFT Pharmaceuticals Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about AFT Pharmaceuticals Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of AFT Pharmaceuticals Ltd.?
      To buy shares of AU:AFP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis